Effect of GLP-1 receptor agonists on gum disease treatment
Part of Hormones & metabolism, Mouth & dental clinical trials.
This study looks at how GLP-1 receptor agonists (medicines for diabetes or weight loss) affect the results of non-surgical gum disease treatment in adults with overweight and periodontitis. If you are 18-65, have a BMI of 25 or higher, have gum disease, and have at least 20 teeth, you may be eligible. Participants will either continue their usual care or take a GLP-1 medicine, and then receive standard gum treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 65 years
- Body mass index (BMI) 25 or higher
- Diagnosis of periodontitis (gum disease)
- At least 20 natural teeth
- For GLP-1 group: regular GLP-1 receptor agonist use for at least 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating gum disease can help improve blood sugar control in people with type 2 diabetes. If you have poorly controlled diabetes and gum disease, you may be able to join this study.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
This study tests whether a type 2 diabetes medicine (a GLP-1 receptor agonist) can also help treat gum disease. If you have both diabetes and gum problems, you may be able to join.
This study looks at how inflammation in the gums relates to genes in adults with obesity. Researchers want to understand why some people with obesity develop more gum disease, which could lead to better treatments.
This study tests whether adding a special light-activated cleaning (antimicrobial photodynamic therapy) to standard gum disease treatment can help people with obesity who have gum disease. It aims to see if this extra step improves gum health more than standard treatment alone.
This study tests a simple plan to help people with overweight and related health risks lose weight over a long time. You would follow the plan at home, chew a special gum, and send in a stool sample to see how your gut health changes.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.